Kyne S, Ní Shíocháin D, McDonnell C, Byrne A, Sutton-Fitzpatrick U, Crowley N, Nertney L, Myers C, Waldron J, Ahmed A, Wrynne C, Fennell J, Fitzpatrick P, Fitzsimons JJ, Scanlan B, Vaughan D, Gorman KM, Cunney R, Smyth AE, Hourihane JO., Increased rates of invasive bacterial disease in late 2022., European journal of pediatrics, 2023,
Journal Article,
PUBLISHED
DOI
|
Kavanagh N, Ryan EJ, Widaa A, Sexton G, Fennell J, O'Rourke S, Cahill KC, Kearney CJ, O'Brien FJ, Kerrigan SW., Staphylococcal Osteomyelitis: Disease Progression, Treatment Challenges, and Future Directions., Clinical Microbiology Reviews, 31, (2), 2018, p1-25 ,
Journal Article,
PUBLISHED
DOI
|
Byrne CJ, Parton T, McWhinney B, Fennell JP, O'Byrne P, Deasy E, Egan S, Enright H, Desmond R, Ryder SA, D'Arcy DM, McHugh J, Roberts JA, Population pharmacokinetics of total and unbound teicoplanin concentrations and dosing simulations in patients with haematological malignancy, Journal of Antimicrobial Chemotherapy, 73, (4), 2018, p995 - 1003,
Journal Article,
PUBLISHED
DOI
URL
|
Murphy CM, Di Ruscio F, Lynskey M, Collins J, McCullough E, Cosgrave R, McDonnell D, Fennell J, Identification badge lanyards as infection control risk: a cross-sectional observation study with epidemiological analysis, Journal of Hospital Infection, 96, (1), 2017, p63 - 66,
Notes: [Staphylococcus aureus cultures from name badge lanyards were phenotypically and genotypically indistinguishable from the wearer's nasal carrier strains by pulsed-field gel electrophoresis and antibiogram. Lanyards had a mean age of 22 months and hygiene was poor with only 9% ever having been laundered. Molecular analysis showed that 26% of S. aureus nasal carriers shared an indistinguishable strain on their lanyard. Lanyards should not be recommended for staff in frontline clinical care.],
Journal Article,
PUBLISHED
|
Byrne CJ, Roberts JA, McWhinney B, Fennell JP, O'Byrne P, Deasy E, Egan S, Desmond R, Enright H, Ryder SA, D'Arcy DM, McHugh J, Variability in trough total and unbound teicoplanin concentrations and achievement of therapeutic drug monitoring targets in adult patients with haematological malignancy, Antimicrobial Agents and Chemotherapy, 61, (6), 2017, pe02466-16 ,
Notes: [PMID: 28320714],
Journal Article,
PUBLISHED
TARA - Full Text
DOI
|
Byrne CJ, Roberts JA, McWhinney B, Ryder SA, Fennell JP, O'Byrne P, Deasy E, Egan S, Desmond R, Enright H, D'Arcy DM, McHugh J, Population pharmacokinetics of teicoplanin and attainment of pharmacokinetic/pharmacodynamic targets in adult patients with haematological malignancy, Clinical Microbiology and Infection, 23, (9), 2017, p674.e7-674.e13 ,
Notes: [PMID: 28267636],
Journal Article,
PUBLISHED
TARA - Full Text
DOI
Handle
|
O'Kelly F, Kavanagh S, Manecksha R, Thornhill J, Fennell JP, Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland., BMC Infectious Diseases, 16, (1), 2016, p620-,
Journal Article,
PUBLISHED
|
Gunning H, Taylor G, Smyth A, Mellotte G, Fennell J, Murphy P, Lavin P, Wall C, An Approach to Optimise Therapeutic Vancomycin Dosage in a Haemodialysis Population., Irish Medical Journal, 109, (9), 2016, p465-,
Journal Article,
PUBLISHED
|
Byrne CJ, Egan S, Fennell JP, O'Byrne P, Enright H, Deasy E, Ryder SA, D'Arcy DM, McHugh J, Teicoplanin use in adult patients with haematological malignancy: Exploring relationships between dose, trough concentrations, efficacy and nephrotoxicity, International Journal of Antimicrobial Agents, 46, (4), 2015, p406 - 412,
Notes: [PMID: 26228465],
Journal Article,
PUBLISHED
DOI
URL
URL
|
Brown AF, Murphy AG, Lalor SJ, Leech JM, O'Keeffe KM, Mac Aogáin M, O'Halloran DP, Lacey KA, Tavakol M, Hearnden CH, Fitzgerald-Hughes D, Humphreys H, Fennell JP, van Wamel WJ, Foster TJ, Geoghegan JA, Lavelle EC, Rogers TR, McLoughlin RM, Memory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection., PLoS pathogens, 11, (11), 2015, pe1005226 ,
Journal Article,
PUBLISHED
TARA - Full Text
DOI
|
|